相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reagents for Astatination of Biomolecules. 6. An Intact Antibody Conjugated with a Maleimido-closo-Decaborate(2-) Reagent via Sulfhydryl Groups Had Considerably Higher Kidney Concentrations than the Same Antibody Conjugated with an Isothiocyanato-closo-Decaborate(2-) Reagent via Lysine Amines
D. Scott Wilbur et al.
BIOCONJUGATE CHEMISTRY (2012)
What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?
Joseph G. Jurcic
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2012)
Reagents for Astatination of Biomolecules. 5. Evaluation of Hydrazone Linkers in 211At- and 125I-Labeled closo-Decaborate(2-) Conjugates of Fab′ as a Means of Decreasing Kidney Retention
D. Scott Wilbur et al.
BIOCONJUGATE CHEMISTRY (2011)
Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model
John M. Pagel et al.
BLOOD (2011)
Ex vivo characterization and isolation of rare memory B cells with antigen tetramers
Bettina Franz et al.
BLOOD (2011)
Chemical and Radiochemical Considerations in Radiolabeling with alpha-Emitting Radionuclides
D. Scott Wilbur
CURRENT RADIOPHARMACEUTICALS (2011)
Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease
Steven I. Park et al.
BLOOD (2010)
Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia
Todd L. Rosenblat et al.
CLINICAL CANCER RESEARCH (2010)
The α-Camera: A Quantitative Digital Autoradiography Technique Using a Charge-Coupled Device for Ex Vivo High-Resolution Bioimaging of α-Particles
Tom Back et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome
John M. Pagel et al.
BLOOD (2009)
Glomerular Filtration Rate After Alpha-Radioimmunotherapy with 211At-MX35-F(ab′)2: A Long-Term Study of Renal Function in Nude Mice
Tom Back et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Alpha-particles for targeted therapy
George Sgouros
ADVANCED DRUG DELIVERY REVIEWS (2008)
Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy
John M. Pagel et al.
BLOOD (2008)
[(211) At] Astatine-Labeled Compound Stability: Issues with Released [(211) At] Astatide and Development of Labeling Reagents to Increase Stability
D. Scott Wilbur
CURRENT RADIOPHARMACEUTICALS (2008)
Targeted α-particle radiotherapy with 211At-labeled monoclonal antibodies
Michael R. Zalutsky et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission
JM Pagel et al.
BLOOD (2006)
Selective internalization of monoclonal antibodies by B-cell chronic lymphocytic leukaemia cells
T Sieber et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas
JM Pagel et al.
BLOOD (2003)
Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide
L Luznik et al.
BLOOD (2001)
分享论文
